Opnurasib

Opnurasib (JDQ-443) is an orally available and selective and potent covalent KRAS G12C inhibitor with antitumor activity for the study of advanced non-small cell lung cancer.

Product Specifications

CAS Number

2653994-08-0

Stability

≥ 2 years

Purity

>98% (HPLC)

Weight

526.03

Molecular Formula

C29H28ClN7O

Notes

Research use only, not for human use.

Receptor

Kras

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

NBP2-53131PE 0.1 mL

Rat Monoclonal Gr-1/Ly-6G Antibody (1A8) [PE]

View Details

W1018-50F-Biotin 100 µL

West Nile Virus, Envelope (CT) (West Nile Virus E Protein, WNV Envelope Protein, Envelope Protein, Genome Polyprotein, Major Envelope Protein E, WNVgp1) (Biotin) discontinued

View Details

KLR1562 96 Well

Rat 2, 3-Diphosphoglycerate, 2, 3-DPG GENLISA ELISA

View Details

SM1082F 100 µg

CD24 Mouse Monoclonal Antibody [Clone ID: SN3]

View Details

orb579640 100 µL

MAP4K1 Rabbit Polyclonal Antibody

View Details

VAng-Lsx01625-50gEcoli 50 µg (E. coli)

Recombinant Clostridium Tetani glmM Protein (aa 1-448)

View Details